Sewoon Medical Co. Ltd (100700) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sewoon Medical Co. Ltd (100700) has a cash flow conversion efficiency ratio of 0.033x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.98 Billion ≈ $3.37 Million USD) by net assets (₩150.08 Billion ≈ $101.71 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Sewoon Medical Co. Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Sewoon Medical Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 100700 liabilities breakdown for a breakdown of total debt and financial obligations.
Sewoon Medical Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sewoon Medical Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Wilmar Cahaya Indonesia Tbk
JK:CEKA
|
-0.075x |
|
Shanghai Taihe Water Environmental Technology Development Co Ltd
SHG:605081
|
-0.031x |
|
Duluth Holdings Inc
NASDAQ:DLTH
|
-0.042x |
|
Woorison F&G Co. Ltd
KQ:073560
|
0.051x |
|
Queenco-L
TA:QNCO
|
0.072x |
|
Hauman Technologies
TWO:6218
|
-0.008x |
|
Hunter Group ASA
OL:HUNT
|
-0.134x |
|
Omer-Decugis & Cie
PA:ALODC
|
0.124x |
Annual Cash Flow Conversion Efficiency for Sewoon Medical Co. Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Sewoon Medical Co. Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Sewoon Medical Co. Ltd worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩146.12 Billion ≈ $99.02 Million |
₩13.19 Billion ≈ $8.94 Million |
0.090x | -46.16% |
| 2023-12-31 | ₩137.69 Billion ≈ $93.31 Million |
₩23.08 Billion ≈ $15.64 Million |
0.168x | +122.18% |
| 2022-12-31 | ₩123.01 Billion ≈ $83.36 Million |
₩9.28 Billion ≈ $6.29 Million |
0.075x | -59.90% |
| 2021-12-31 | ₩114.13 Billion ≈ $77.35 Million |
₩21.47 Billion ≈ $14.55 Million |
0.188x | -0.36% |
| 2020-12-31 | ₩101.98 Billion ≈ $69.11 Million |
₩19.25 Billion ≈ $13.05 Million |
0.189x | +33.34% |
| 2019-12-31 | ₩95.22 Billion ≈ $64.53 Million |
₩13.48 Billion ≈ $9.14 Million |
0.142x | +0.25% |
| 2018-12-31 | ₩86.35 Billion ≈ $58.52 Million |
₩12.19 Billion ≈ $8.26 Million |
0.141x | +33.38% |
| 2017-12-31 | ₩77.72 Billion ≈ $52.67 Million |
₩8.23 Billion ≈ $5.58 Million |
0.106x | +21.89% |
| 2016-12-31 | ₩73.09 Billion ≈ $49.53 Million |
₩6.35 Billion ≈ $4.30 Million |
0.087x | +56.05% |
| 2015-12-31 | ₩65.61 Billion ≈ $44.47 Million |
₩3.65 Billion ≈ $2.48 Million |
0.056x | -57.37% |
| 2014-12-31 | ₩64.35 Billion ≈ $43.61 Million |
₩8.40 Billion ≈ $5.69 Million |
0.131x | -20.28% |
| 2013-12-31 | ₩58.72 Billion ≈ $39.80 Million |
₩9.62 Billion ≈ $6.52 Million |
0.164x | +16.78% |
| 2012-12-31 | ₩51.25 Billion ≈ $34.73 Million |
₩7.19 Billion ≈ $4.87 Million |
0.140x | +26.92% |
| 2011-12-31 | ₩46.71 Billion ≈ $31.65 Million |
₩5.16 Billion ≈ $3.50 Million |
0.111x | -- |
About Sewoon Medical Co. Ltd
Sewoon Medical Co., Ltd. engages in the research and development, manufacture, and sale of medical products. Its products include wound drainage systems, urinary catheters and tubes, drainage catheters and tubes, respiratory and tracheal tubes, infusion catheters and tubes, and wound care products. The company also offers unigel, thermosens, epistim, bonastent, and other products. Sewoon Medical … Read more